Roivant Sciences Ltd. · NASDAQ:ROIV

Venker Eric sold 200,000 Roivant Sciences Ltd. shares (Form 4)

Traded Sep 30, 2026 · Filed Oct 2, 2026

On Sep 30, 2026, Venker Eric (President & Immunovant CEO) sold 200,000 Roivant Sciences Ltd. shares at US$36.62 for US$7.32M under a trading plan, leaving 1,599,154 shares. Filed Oct 2, 2026 (Form 4).

Sold: 200,000 shares
Price: US$36.62
Value: US$7.32M
Holding after: 1,599,154 shares
Trading plan: Yes (Made under a plan set in advance)
Role: President & Immunovant CEO

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Sep 30, 2026	Common Shares	Option exercise	200,000	US$3.85	1,799,154	Direct
Sep 30, 2026	Common Shares	Sale	200,000	US$36.62	1,599,154	Direct

Source

View original at SEC

Related